MARKET

SPPI

SPPI

Spectrum Pharmaceuticals Inc
NASDAQ
0.4476
+0.0326
+7.86%
Pre Market: 0.4499 +0.0023 +0.51% 06:55 10/05 EDT
OPEN
0.4207
PREV CLOSE
0.4150
HIGH
0.4500
LOW
0.4101
VOLUME
53.87K
TURNOVER
--
52 WEEK HIGH
2.450
52 WEEK LOW
0.4100
MARKET CAP
84.22M
P/E (TTM)
-0.6276
1D
5D
1M
3M
1Y
5Y
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the total NME approvals for the year to 24. This is far less than the 40 approvals received by the same time last year.
Benzinga · 2d ago
The Petri Dish: iSpecimen's founding CEO, longtime COO depart
Christopher Ianelli, founder and CEO of iSpecimen, is leaving the company following a "mutual agreement" between him and the board of directors.
American City Business Journals · 6d ago
Spectrum (SPPI) Down as FDA Panel Votes Against NSCLC Drug
The FDA Oncologic Drugs Advisory Committee votes against Spectrum's (SPPI) poziotinib for treating non-small cell lung cancer in previously treated patients with HER2 exon 20 mutations. Stock down.
Zacks · 09/26 16:09
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
Benzinga · 09/26 07:43
Dow Hits New 2022 Low; Gold Falls Sharply
U.S. stocks extended losses toward the end of trading, with the Dow Jones dropping to a fresh low for the year.
Benzinga · 09/23 18:57
Despite Regulatory Setback, Spectrum Still "Unique Investment Opportunity," Says Analyst
Benzinga · 09/23 17:50
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day extension to March 13, 2023 to regain compliance.
Benzinga · 09/23 16:16
Nasdaq Tumbles Over 200 Points; Crude Oil Drops Sharply
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday.
Benzinga · 09/23 16:15
More
About SPPI
Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of in-development drug products for the treatment of cancer patients. The Company's pipeline products include Eflapegrastim and Poziotinib. The Eflapegrastim is a long-acting granulocyte colony-stimulating factor (G-CSF) for chemotherapy-induced neutropenia. Poziotinib is a, pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR) family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations. The Eflapegrastim employs a LAPSCOVERY technology to enhance the duration of therapeutic effects and reduce the frequency of administration.

Webull offers kinds of Spectrum Pharmaceuticals, Inc. stock information, including NASDAQ:SPPI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPPI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SPPI stock methods without spending real money on the virtual paper trading platform.